Shares of Encompass Health Corp (AMEX:EHC) have received an average recommendation of “Buy” from the eleven ratings firms that are currently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $71.00.
A number of equities analysts have recently commented on the stock. Zacks Investment Research downgraded shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Tuesday. Mizuho restated a “buy” rating and set a $82.00 price objective on shares of Encompass Health in a research note on Thursday, July 26th. Piper Jaffray Companies upgraded shares of Encompass Health from a “neutral” rating to an “overweight” rating in a research note on Thursday, July 26th. Credit Suisse Group increased their price objective on shares of Encompass Health from $66.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, July 26th. Finally, SunTrust Banks restated a “buy” rating and set a $82.00 price objective on shares of Encompass Health in a research note on Friday, July 20th.
Shares of AMEX EHC opened at $57.67 on Friday. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 1.89. Encompass Health has a 1-year low of $40.86 and a 1-year high of $59.29.
Encompass Health (AMEX:EHC) last announced its earnings results on Wednesday, July 25th. The company reported $0.99 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.83 by $0.16. The firm had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.03 billion. Encompass Health had a net margin of 8.67% and a return on equity of 23.56%. The firm’s revenue was up 10.5% on a year-over-year basis. research analysts anticipate that Encompass Health will post 2.72 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 15th. Stockholders of record on Monday, October 1st will be paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.87%. This is an increase from Encompass Health’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Friday, September 28th.
In other news, insider Cheryl B. Levy sold 28,955 shares of the company’s stock in a transaction dated Friday, August 3rd. The shares were sold at an average price of $78.00, for a total value of $2,258,490.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Andrew L. Price sold 9,457 shares of the company’s stock in a transaction dated Tuesday, August 14th. The shares were sold at an average price of $80.04, for a total transaction of $756,938.28. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.
Several hedge funds have recently modified their holdings of EHC. Harvest Fund Management Co. Ltd bought a new stake in shares of Encompass Health in the 2nd quarter valued at about $107,000. Bridgeworth LLC bought a new stake in shares of Encompass Health in the 2nd quarter valued at about $127,000. Point72 Asia Hong Kong Ltd bought a new stake in shares of Encompass Health in the 1st quarter valued at about $142,000. Meeder Asset Management Inc. raised its holdings in shares of Encompass Health by 97.0% in the 2nd quarter. Meeder Asset Management Inc. now owns 2,092 shares of the company’s stock valued at $142,000 after purchasing an additional 1,030 shares during the period. Finally, Mount Yale Investment Advisors LLC bought a new stake in shares of Encompass Health in the 1st quarter valued at about $143,000. 93.18% of the stock is currently owned by institutional investors.
Encompass Health Company Profile
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Further Reading: Understanding Analyst Recommendations
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.